News
Tightened pollution standards a breath of fresh air to pulmonologists
Stricter standards for acceptable levels of fine particulate matter in air promise to improve pulmonary health and reduce pollution-related...
News
Patients haunted by fears of living with and dying from severe lung disease
Depression and anxiety are highly prevalent among patients with severe, chronic obstructive lung diseases, and require a multi-prong treatment...
News
Despite Good Prognosis, Early Melanoma Sparks Fear of Recurrence
In a small study, patients successfully treated for early, localized cutaneous melanoma expressed anxieties about recurrence, life changes, and...
News
Oral IL-23 Inhibitor Calms Moderate to Severe Psoriasis
The impact on psoriasis of higher doses of JNJ-77242113 at week 16 "was similar in magnitude to the responses seen with several of the injectable...
News
Patients With Stable Lupus May Be Safely Weaned Off MMF
Rates of significant disease reactivation were similar more than 1 year after randomization for patients assigned to mycophenolate mofetil (MMF)...
News
New Findings on Vitamin D, Omega-3 Supplements for Preventing Autoimmune Diseases
Omega-3 fatty acid supplements prevented autoimmune diseases for 2 years after cessation, but vitamin D’s effects tapered off, suggesting that...
News
Small PFS gain in metastatic prostate cancer with TKI and ICI
Expert questions the choice of an androgen receptor pathway inhibitor (ARPI) switch as the control arm of the study.
News
Combo Tx Best in Metastatic Prostate Cancer with HRR Mutations
PFS was better with abiraterone/prednisone and olaparib vs. monotherapy in men with metastatic castration-resistant prostate cancer with DNA...
News
High-dose RT and long-term ADT improve survival in high-risk prostate cancer
These results are “practice-affirming for many,” according to an expert commenting on the new findings.
News
In Transplant-Ineligible Myeloma, This Frontline Tx Is Better
New study finds a top performer among “preferred” treatment combos for patients with multiple myeloma who can’t get stem cell transplants.
News
Measurable residual disease–guided therapy promising for CLL
Phase-3 analysis shows that a drug combo for chronic lymphocytic leukemia yielded better outcomes than chemoimmunotherapy.
News
Distinct toxicity profiles for anti-BCMA myeloma therapies
New FDA data analysis shows CAR T-cell and other anti-BCMA treatments for multiple myeloma are linked to considerable risks for side effects.
News
Sickle Cell Gene Therapy ‘Truly Transformative’
New research on a just-approved gene therapy for sickle cell disease shows the efficacy of a single infusion of lovo-cel.
News
Low-dose aspirin reduces liver fat, inflammation markers
“I’m encouraged by the results with low-dose aspirin, and I think that, given the risk profile, using a lower dose is preferable.”
News
Weight-loss drugs improve liver measures, too
Body weight reduction of at least 3% within 8 weeks of beginning treatment with either an SLT-2 or GLP-1 agent was associated independently with...